Literature DB >> 20687609

Alpha,beta-unsaturated N-acylpyrrole peptidyl derivatives: new proteasome inhibitors.

Anna Baldisserotto1, Valeria Ferretti, Federica Destro, Christian Franceschini, Mauro Marastoni, Riccardo Gavioli, Roberto Tomatis.   

Abstract

Because of the encouraging results obtained using vinyl ester derivatives, we synthesized and tested a novel series of peptide-based proteasome inhibitors bearing a new pharmacophore unit at the C-terminal. N-Acylpyrrole moiety is a potential substrate for Michael addition by catalytic threonine. Several analogues have demonstrated a selective inhibition of the multicatalytic complex beta1 subunits, the capacity to permeate cellular membrane, and good pharmacokinetics properties.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20687609     DOI: 10.1021/jm100122e

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Fundamental reaction pathway for peptide metabolism by proteasome: insights from first-principles quantum mechanical/molecular mechanical free energy calculations.

Authors:  Donghui Wei; Lei Fang; Mingsheng Tang; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2013-10-10       Impact factor: 2.991

2.  Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors.

Authors:  Salvatore Pacifico; Valeria Ferretti; Valentina Albanese; Anna Fantinati; Eleonora Gallerani; Francesco Nicoli; Riccardo Gavioli; Francesco Zamberlan; Delia Preti; Mauro Marastoni
Journal:  ACS Med Chem Lett       Date:  2019-06-06       Impact factor: 4.345

3.  Fundamental reaction pathway and free energy profile for inhibition of proteasome by Epoxomicin.

Authors:  Donghui Wei; Beilei Lei; Mingsheng Tang; Chang-Guo Zhan
Journal:  J Am Chem Soc       Date:  2012-06-14       Impact factor: 15.419

4.  Fundamental reaction pathway and free energy profile of proteasome inhibition by syringolin A (SylA).

Authors:  Donghui Wei; Mingsheng Tang; Chang-Guo Zhan
Journal:  Org Biomol Chem       Date:  2015-06-28       Impact factor: 3.876

5.  Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.

Authors:  Jonghoon Park; Eok Park; Cheol-Kyu Jung; Seung-Wan Kang; Byung Gyu Kim; Youngjoo Jung; Tae Hun Kim; Ji-Young Lim; Sung-Eun Lee; Chang-Ki Min; Kwang-Ai Won
Journal:  BMC Cancer       Date:  2016-03-24       Impact factor: 4.430

Review 6.  Revisiting Proteasome Inhibitors: Molecular Underpinnings of Their Development, Mechanisms of Resistance and Strategies to Overcome Anti-Cancer Drug Resistance.

Authors:  Carlota Leonardo-Sousa; Andreia Neves Carvalho; Romina A Guedes; Pedro M P Fernandes; Natália Aniceto; Jorge A R Salvador; Maria João Gama; Rita C Guedes
Journal:  Molecules       Date:  2022-03-28       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.